Status:
COMPLETED
Baroreflex Sensitivity in Patients Undergoing Ablation of Atrial Fibrillation
Lead Sponsor:
Poitiers University Hospital
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18-99 years
Brief Summary
Atrial fibrillation is the most common arrhythmia. The posterior surface of the left atrium is covered by an extensive network belonging to the autonomic nervous system that can be damaged during the ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old,
- Patients with paroxysmal atrial fibrillation, hospitalized for atrial fibrillation ablation,
- Assessable baroreflex sensitivity before ablation,
- Free subject, without guardianship or curatorship or subordination,
- Patients benefiting from a Social Security assurance,
- Informed consent signed by the patient after clear and fair information about the study.
Exclusion
- Age \< 18,
- History of atrial fibrillation ablation,
- Inability to calculate the baroreflex sensitivity
- Contraindication to the performance of a cardiac CT scan (allergy to iodine, severe renal insufficiency with clearance \<30 ml/mn/m2),
- Inability to have continuous ECG recording by subcutaneous Holter,
Key Trial Info
Start Date :
June 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 13 2025
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04503122
Start Date
June 22 2021
End Date
November 13 2025
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Poitiers
Poitiers, France